APSR2026-750

Yes
Late-Breaking
Submitted
Poster Presentation
 
AP04-016
P103
 
Format: PPTX Only
https://storage.unitedwebnetwork.com/files/1285/1221195-46904-APSR26_MURILLO_Leptospirosis_DAH_Poster_433898.pdf
Format: PDF Only
11. Critical Care Medicine
2

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Karl Jeffrey Murillo * Philippine General Hospital Division of Pulmonary Medicine, Department of Medicine Manila Philippines
Ralph Elvi Villalobos - Division of Pulmonary Medicine, Department of Medicine Division of Pulmonary Medicine, Department of Medicine Manila Philippines
 
 
 
 
 
 
 
 
 
 
 
 
 
Presenting Author Details
Karl Jeffrey
Murillo
karljeffrey.murillo@gmail.com
+639173087667
31-40
Philippines
Case Report
High-Flow Nasal Oxygen as a Noninvasive Strategy in Leptospirosis-Associated Diffuse Alveolar Hemorrhage: A Goal-Concordant Approach
Maximum 25 words
Abstract Content
 
 
 
 
Diffuse alveolar hemorrhage (DAH) in leptospirosis is associated with high mortality and frequently necessitates invasive mechanical ventilation. However, the role of high-flow nasal oxygen (HFNO) as an alternative strategy in selected patients remains unclear, particularly when invasive ventilation is not aligned with patient preferences.
A 25-year-old man presented with fever, jaundice, and acute hypoxemic respiratory failure following floodwater exposure. Oxygen saturation was 83% on room air. Arterial blood gas showed severe hypoxemia (PaO₂ 37 mmHg on FiO₂ approximately 0.8) with metabolic acidosis. Chest radiograph revealed diffuse bilateral alveolar infiltrates. Laboratory findings demonstrated thrombocytopenia, acute kidney injury, and hyperbilirubinemia consistent with severe leptospirosis. Serology confirmed leptospiral infection . Despite repeated counseling, the patient declined intubation and signed do-not-intubate directives. Given preserved mental status and hemodynamic stability, HFNO was initiated at flows up to 60 L/min with FiO₂ 1.0 under close ICU monitoring. The patient received intravenous ceftriaxone, pulse corticosteroids, and renal replacement therapy. Progressive improvement in oxygenation and respiratory parameters was observed, allowing successful weaning from HFNO without invasive ventilation. The patient was discharged on room air
Diffuse alveolar hemorrhage in leptospirosis is traditionally managed with early intubation due to severe hypoxemia. This case demonstrates that HFNO may provide adequate oxygenation and reduce work of breathing while avoiding airway instrumentation, which may exacerbate bleeding. Importantly, this approach aligns with patient preferences in situations where invasive ventilation is declined. Careful patient selection is essential, including preserved consciousness, hemodynamic stability, and absence of impending respiratory arrest. In resource-limited settings, HFNO may serve as a pragmatic and goal-concordant strategy in select cases.
 
 
No
No
 
JPG or JPEG or PNG format ONLY
Diffuse alveolar hemorrhage, Leptospirosis, High flow nasal oxygen
maximum 3 keywords and no abbreviations, separated by commas
The authors declare no conflicts of interest. No external funding was received for this study.
260